GlobalBridge’s Idexx Laboratories IDXX Stock Holding History

GlobalBridge’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-4,336	Closed	-$216K	–	339
2013 Q3	$216K	Buy	+4,336	New	+$208K	0.12%	281

Other funds holding IDXX

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GlobalBridge's IDXX Position: Q4 2013 in Review

GlobalBridge sold out of Idexx Laboratories (IDXX) in Q4 2013, closing a stake of 4,336 shares — an estimated $216K sold.

GlobalBridge first reported a position in IDXX in Q3 2013 and held it in 1 quarter. The position peaked at $216K in Q3 2013. 298 funds tracked by Wall St. Rank hold IDXX as of Q4 2013.

GlobalBridge reported no remaining Idexx Laboratories position as of Q4 2013 after selling out during the quarter.
GlobalBridge sold 4,336 Idexx Laboratories shares in Q4 2013, an estimated $216K.
GlobalBridge first reported a position in Idexx Laboratories in Q3 2013 and held it in 1 quarter.
GlobalBridge's Idexx Laboratories position peaked at $216K in Q3 2013.
298 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2013.

Based on GlobalBridge's 13F filing for Q4 2013, filed 16 Jan 2014.